Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FYBWZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,868
Award facts
- Contract value 100% obligated
- $13,867.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,867.74 for RINVOQ ER 15 MG tablets (30-count units) on August 25, 2025, with completion scheduled for August 26, 2025. This firm fixed-price contract was competitively awarded without a set-aside designation and will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. RINVOQ is a prescription medication used to treat rheumatoid arthritis and other autoimmune conditions, representing the type of specialty pharmaceutical products that AmerisourceBergen routinely supplies through federal medical procurement channels.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion vehicle through December 2026 that serves as a comprehensive global pharmaceutical support program for military healthcare systems. The parent IDC enables the company to supply an extensive range of pharmaceutical products, vaccines, and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities worldwide. AmerisourceBergen's status as a major pharmaceutical distributor and its consistent track record of meeting federal procurement requirements through open competition demonstrate the company's critical role in supporting military medical supply chains.
Quick answers
Who was awarded contract SPE2DB25FYBWZ?
SPE2DB25FYBWZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DB25FYBWZ worth?
The government has obligated $13,868 on SPE2DB25FYBWZ.
Is contract SPE2DB25FYBWZ an order under another contract?
Yes. SPE2DB25FYBWZ is a delivery order under SPE2DB20D3505, an indefinite delivery contract.
Was contract SPE2DB25FYBWZ competed?
The extent of competition for SPE2DB25FYBWZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award